Genetic Technologies Limited (GNTLF)
GNTLF Stock Price Chart
Explore Genetic Technologies Limited interactive price chart. Choose custom timeframes to analyze GNTLF price movements and trends.
GNTLF Company Profile
Discover essential business fundamentals and corporate details for Genetic Technologies Limited (GNTLF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
19 Oct 2000
Employees
55.00
Website
https://www.gtglabs.comCEO
Kevin Camilleri
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.
GNTLF Financial Timeline
Browse a chronological timeline of Genetic Technologies Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 20 Aug 2025
Earnings released on 2 Jun 2025
Earnings released on 28 Mar 2025
Earnings released on 24 Feb 2025
Earnings released on 29 Aug 2024
EPS came in at -$0.03 , while revenue for the quarter reached $2.47M , missing expectations by -17.62%.
Earnings released on 29 Apr 2024
Earnings released on 23 Feb 2024
EPS came in at -$0.04 , while revenue for the quarter reached $2.70M , missing expectations by -5.74%.
Earnings released on 30 Jan 2024
EPS came in at -$0.02 , while revenue for the quarter reached $1.56M .
Stock split effective on 14 Dec 2023
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 11 Dec 2023
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 4 Dec 2023
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 24 Nov 2023
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Aug 2023
EPS came in at -$0.04 , while revenue for the quarter reached $3.01M .
Earnings released on 31 Mar 2023
EPS came in at -$0.02 , while revenue for the quarter reached $1.80M , missing expectations by -62.92%.
Earnings released on 31 Dec 2022
EPS came in at -$0.04 , while revenue for the quarter reached $2.84M .
Earnings released on 30 Sept 2022
EPS came in at -$0.02 , while revenue for the quarter reached $1.61M , missing expectations by -67.57%.
Earnings released on 30 Aug 2022
EPS came in at -$0.02 , while revenue for the quarter reached $3.26M .
Earnings released on 31 Mar 2022
EPS came in at -$0.01 , while revenue for the quarter reached $2.16M .
Earnings released on 24 Feb 2022
EPS came in at -$0.03 , while revenue for the quarter reached $1.49M .
Earnings released on 30 Sept 2021
EPS came in at -$0.02 , while revenue for the quarter reached $1.25M .
Earnings released on 31 Aug 2021
EPS came in at -$0.03 , while revenue for the quarter reached $78.17K .
Earnings released on 31 Mar 2021
EPS came in at -$0.02 , while revenue for the quarter reached $501.82K .
Earnings released on 31 Dec 2020
EPS came in at -$0.03 , while revenue for the quarter reached $12.60K .
Stock split effective on 14 Dec 2020
Shares were split 15 : 14 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 22 Oct 2020
EPS came in at -$0.05 , while revenue for the quarter reached $6.43K .
Earnings released on 30 Sept 2020
EPS came in at -$0.02 , while revenue for the quarter reached $5.89K .
GNTLF Stock Performance
Access detailed GNTLF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.